miRNA-mediated modulation of the IL-6-signaling pathway has been extensively investigated in several neoplasms, such as breast [193], colorectal [194], lung [195], and prostate cancer [196] and multiple myeloma [197], but it is still not explored in LSCC. The gene discussed is IL6; the disease is neoplasm.